Stock Market Reviews

SIBN (SI-BONE, Inc.) News

Get the latest news, insights, and market updates on SIBN (SI-BONE, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Investors in SI-BONE (NASDAQ:SIBN) have seen favorable returns of 40% over the past year
  These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...
  Jan 5, 2026 - $SIBN
• SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham
  Needham analyst David Saxon raised the firm’s price target on SI-Bone (SIBN) to $27 from $24 and keeps a Buy rating on the shares. The firm has also added the stock to its ‘Conviction List’, replacing Alcon (ALC) and named it Needham’s ‘2026 Top Pick’. Needham believes that SI-Bone can deliver potential upside to estimates over the near-term, which should drop through to drive increasing profitability. The firm further notes that the company’s upcoming product launches could result in active sur
  Dec 17, 2025 - $SIBN
• Should You Buy Si-Bone (SIBN) After Golden Cross?
  Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
  Dec 5, 2025 - $SIBN
• Galvanize Therapeutics Appoints Laura Francis to its Board of Directors
  Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the appointment of Laura Francis to its Board of Directors.
  Nov 24, 2025 - $SIBN
• SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
  SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time/ 12:00 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at
  Nov 18, 2025 - $SIBN
• SI-BONE Inc (SIBN) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ...
  SI-BONE Inc (SIBN) reports a 21% revenue increase and outlines future growth strategies amid new product developments and market expansion.
  Nov 11, 2025 - $SIBN
• Why SI-Bone Stock Was Crushing It Today
  Take-up of the company's wares among physicians is rising significantly.
  Nov 11, 2025 - $SIBN
• Si-Bone (SIBN) Reports Q3 Loss, Beats Revenue Estimates
  Si-Bone (SIBN) delivered earnings and revenue surprises of +31.25% and +4.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 10, 2025 - $SIBN
• Si-Bone: Q3 Earnings Snapshot
  SANTA CLARA, Calif. AP) — Si-Bone Inc. SIBN) on Monday reported a loss of $4.6 million in its third quarter.
  Nov 10, 2025 - $SIBN
• SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
  Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.7 million, representing growth of 20.6% U.S. revenue of $46.4 million, representing growth of 21.2%Gross margin of 79.8%, representing an improvement of 75 basis pointsNet loss of $4.6 million, representing an improvement of 30.6% Positive adjusted EBITDA of $
  Nov 10, 2025 - $SIBN